Candriam Equities L Biotech.C USD Dis/ LU0108459552 /
| NAV9/21/2023 | Chg.-6.8300 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 679.1400USD | -1.00% | paying dividend | Equity Worldwide | Candriam ▶ |
- Dividends adjusted Dividends adjusted
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2000 | - | - | - | - | 9.07 | 39.65 | -8.01 | 23.69 | 10.72 | -11.24 | -13.74 | 4.18 | - |
| 2001 | -2.63 | -12.28 | -20.64 | 18.86 | 9.28 | 4.98 | -14.90 | 2.77 | -19.22 | 16.98 | 9.78 | 0.03 | -16.11% |
| 2002 | -15.77 | -3.67 | 2.35 | -17.67 | 0.46 | -18.95 | 1.99 | 0.98 | -9.50 | 9.48 | 7.67 | -6.84 | -43.02% |
| 2003 | -4.71 | -4.58 | 6.06 | 7.14 | 20.00 | -3.01 | 7.99 | -2.86 | 2.20 | 2.20 | -1.67 | 6.66 | +38.18% |
| 2004 | 7.08 | 1.56 | -1.42 | -0.39 | -2.54 | -0.01 | -9.09 | 2.22 | 5.78 | -2.11 | 0.82 | 6.14 | +7.16% |
| 2005 | -3.81 | -5.20 | -3.96 | 3.01 | 6.36 | 2.85 | 10.12 | 1.25 | 2.79 | -3.41 | 5.67 | 1.28 | +16.90% |
| 2006 | 6.12 | 3.95 | -3.55 | -4.77 | -4.44 | 0.10 | -2.51 | 2.56 | 0.18 | 13.73 | 0.76 | -2.27 | +8.75% |
| 2007 | 2.28 | -3.54 | 2.02 | 7.47 | 0.08 | -5.87 | -2.83 | 1.87 | 5.50 | 2.14 | -2.82 | -5.94 | -0.65% |
| 2008 | -5.04 | -3.45 | 1.52 | 1.40 | 1.64 | -2.69 | 17.00 | -4.27 | -6.57 | -15.63 | -10.18 | 8.04 | -20.02% |
| 2009 | -1.37 | -7.08 | 6.16 | -0.49 | 2.87 | 7.08 | 29.16 | 2.60 | 1.37 | -11.26 | 7.99 | 5.19 | +44.41% |
| 2010 | 3.27 | 6.32 | 14.94 | -2.02 | -12.51 | -5.73 | 3.62 | -0.48 | 10.70 | 2.68 | -2.59 | 6.17 | +23.65% |
| 2011 | -0.64 | 0.71 | 5.91 | 4.52 | 2.93 | -1.77 | -3.57 | -8.02 | -6.69 | 7.92 | 0.70 | 1.77 | +2.53% |
| 2012 | 11.82 | 0.38 | 5.75 | 0.55 | -2.15 | 5.51 | 2.34 | 1.90 | 5.14 | -5.96 | 4.39 | -1.03 | +31.25% |
| 2013 | 9.66 | 1.02 | 8.07 | 6.09 | 3.28 | -2.76 | 14.25 | -2.44 | 9.93 | -2.81 | 6.52 | 1.60 | +64.40% |
| 2014 | 8.24 | 7.34 | -9.94 | -5.10 | 2.76 | 10.10 | -3.25 | 11.05 | -1.11 | 9.59 | 2.97 | 0.57 | +35.47% |
| 2015 | 4.47 | 4.53 | 1.85 | -5.10 | 10.73 | 0.63 | 4.16 | -10.94 | -11.38 | 7.79 | 3.42 | 0.32 | +8.10% |
| 2016 | -23.25 | -4.59 | 3.67 | 3.77 | 5.58 | -8.41 | 12.55 | -2.39 | 3.96 | -12.73 | 9.10 | -2.85 | -19.51% |
| 2017 | 5.50 | 6.83 | 0.08 | 1.07 | -2.96 | 9.36 | 2.39 | 6.81 | 0.89 | -6.61 | 0.12 | 1.45 | +26.62% |
| 2018 | 6.69 | -4.62 | -2.15 | -3.21 | 4.60 | 0.80 | 4.40 | 4.12 | -2.09 | -14.02 | 4.12 | -8.32 | -11.26% |
| 2019 | 13.12 | 3.56 | -0.58 | -4.95 | -4.48 | 9.42 | -2.22 | -2.37 | -4.52 | 11.18 | 11.96 | 2.77 | +34.92% |
| 2020 | -5.29 | -1.54 | -5.00 | 12.34 | 9.48 | 1.27 | -3.02 | 0.83 | 0.70 | -2.66 | 9.43 | 2.97 | +19.20% |
| 2021 | 1.80 | -2.60 | -4.29 | 2.70 | -2.27 | 6.33 | -1.47 | 3.88 | -4.25 | 0.15 | -4.39 | 2.39 | -2.69% |
| 2022 | -10.59 | -1.56 | 6.03 | -7.24 | -3.98 | 3.49 | 4.70 | 1.52 | -1.91 | 6.49 | 6.17 | -2.88 | -1.52% |
| 2023 | 2.90 | -5.68 | 0.23 | 2.26 | -0.96 | 1.41 | -0.59 | -0.24 | -3.39 | - | - | - | - |
Single months: Dividends not considered
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 14.42% | 13.20% | 17.56% | 20.94% | 23.51% |
| Sharpe ratio | -0.68 | -0.17 | 0.08 | -0.15 | 0.01 |
| Best month | +2.90% | +2.26% | +6.49% | +9.43% | +13.12% |
| Worst month | -5.68% | -3.39% | -5.68% | -10.59% | -14.02% |
| Maximum loss | -10.25% | -7.85% | -11.75% | -30.65% | -30.65% |
| Outperformance | -4.42% | - | -5.67% | +0.19% | -4.92% |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,802.2700 | +6.55% | +3.49% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 196.4300 | -2.35% | - | |
| Candriam Equities L Biotech.I EU... | reinvestment | 1,830.4399 | +3.17% | -3.47% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 1,973.0100 | -1.35% | +13.63% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,079.5701 | -1.86% | +6.29% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 322.4400 | -1.94% | +9.07% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 288.0200 | -1.47% | +15.37% | |
| Candriam Equities L Biotech.R CH... | reinvestment | 181.0200 | +1.47% | -3.93% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,607.4301 | +6.59% | +5.52% | |
| Candriam Equities L Biotech.I US... | reinvestment | 4,983.7998 | +4.99% | +4.19% | |
| Candriam Equities L Biotech.V US... | reinvestment | 527.8700 | +5.02% | +0.90% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 175.6800 | +2.96% | -4.17% | |
| Candriam Equities L Biotech.R US... | reinvestment | 235.7200 | +4.98% | +5.78% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 182.1800 | +3.28% | -1.85% | |
| Candriam Equities L Biotech.C US... | reinvestment | 739.1700 | +5.42% | +2.25% | |
| Candriam Equities L Biotech.C US... | paying dividend | 679.1400 | +5.39% | +2.15% |
Performance
| YTD | -4.27% | ||
|---|---|---|---|
| 6 Months | +0.82% | ||
| 1 Year | +5.39% | ||
| 3 Years | +2.15% | ||
| 5 Years | +22.66% | ||
| 10 Years | +108.76% | ||
| Since start | +635.46% | ||
| Year | |||
| 2022 | -1.52% | ||
| 2021 | -2.69% | ||
| 2020 | +19.20% | ||
| 2019 | +34.92% | ||
| 2018 | -11.26% | ||
| 2017 | +26.62% | ||
| 2016 | -19.51% | ||
| 2015 | +8.10% | ||
| 2014 | +35.47% | ||
Dividends
| 4/28/2023 | 3.92 USD |
| 4/28/2022 | 3.44 USD |
| 4/28/2021 | 5.10 USD |
| 4/24/2020 | 2.36 USD |
| 4/26/2019 | 2.90 USD |
| 4/24/2018 | 4.00 USD |
| 4/25/2017 | 2.50 USD |
| 4/26/2016 | 1.76 USD |
| 4/28/2015 | 8.00 USD |
| 4/29/2014 | 0.70 USD |
| 4/26/2013 | 0.70 USD |
| 4/27/2012 | 0.20 USD |
| 4/29/2011 | 0.20 USD |
| 5/13/2002 | 1.00 USD |